HighTower Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-47,574
| Closed | -$4.85M | – | 3501 |
|
|
2023
Q2 | $4.85M | Sell |
47,574
-1,404
| -3% | -$143K | 0.01% | 921 |
|
|
2023
Q1 | $4.45M | Sell |
48,978
-3,417
| -7% | -$311K | 0.01% | 911 |
|
|
2022
Q4 | $1.99M | Sell |
52,395
-3,755
| -7% | -$143K | ﹤0.01% | 1287 |
|
|
2022
Q3 | $1.41M | Buy |
56,150
+135
| +0.2% | +$3.4K | ﹤0.01% | 1421 |
|
|
2022
Q2 | $1.71M | Buy |
56,015
+1,500
| +3% | +$45.7K | ﹤0.01% | 1344 |
|
|
2022
Q1 | $1.79M | Sell |
54,515
-308
| -0.6% | -$10.1K | ﹤0.01% | 1442 |
|
|
2021
Q4 | $1.45M | Sell |
54,823
-4,267
| -7% | -$113K | ﹤0.01% | 1554 |
|
|
2021
Q3 | $5.94M | Sell |
59,090
-10,170
| -15% | -$1.02M | 0.02% | 743 |
|
|
2021
Q2 | $9.8M | Buy |
69,260
+10,302
| +17% | +$1.46M | 0.03% | 525 |
|
|
2021
Q1 | $5.88M | Sell |
58,958
-35
| -0.1% | -$3.49K | 0.02% | 686 |
|
|
2020
Q4 | $7.3M | Buy |
58,993
+4,155
| +8% | +$514K | 0.03% | 467 |
|
|
2020
Q3 | $5.34M | Buy |
+54,838
| New | +$5.34M | 0.03% | 534 |
|